|
Activity Number:
|
392
|
|
Type:
|
Invited
|
|
Date/Time:
|
Wednesday, August 1, 2007 : 10:30 AM to 12:20 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #308029 |
|
Title:
|
High Throughput Screening (HTS) for Lead and Target Identification
|
|
Author(s):
|
Marc Ferrer*+
|
|
Companies:
|
Merck & Co., Inc.
|
|
Address:
|
502 Louise Lane, North Wales, PA, 19454,
|
|
Keywords:
|
HTS ; lead compounds ; siRNA ; drug discovery
|
|
Abstract:
|
High Throughput Screening (HTS) is now used to test large collections of compounds to identify leads for drug discovery. It is also used to test genome-wide collections of siRNA to probe biological processes to discover new therapeutically relevant targets and pathways. This talk will explain how the process of HTS fully automated for the rapid and cost effective screening.
|
- The address information is for the authors that have a + after their name.
- Authors who are presenting talks have a * after their name.
Back to the full JSM 2007 program |
